Axa’s Omnicell OMCL Stock Holding History

Axa’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-41,300	Closed	-$2.98M	–	1287
2019 Q3	$2.98M	Sell	41,300 -52,800	-56%	-$3.88M	0.01%	785
2019 Q2	$8.1M	Buy	94,100 +84,800	+912%	+$6.89M	0.03%	524
2019 Q1	$752K	Buy	+9,300	New	+$696K	﹤0.01%	1035

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Axa's OMCL Position: Q4 2019 in Review

Axa sold out of Omnicell (OMCL) in Q4 2019, closing a stake of 41,300 shares — an estimated $2.98M sold.

Axa first reported a position in OMCL in Q1 2019 and held it in 3 quarters. The position peaked at $8.1M in Q2 2019. 298 funds tracked by Wall St. Rank hold OMCL as of Q4 2019.

Axa reported no remaining Omnicell position as of Q4 2019 after selling out during the quarter.
Axa sold 41,300 Omnicell shares in Q4 2019, an estimated $2.98M.
Axa first reported a position in Omnicell in Q1 2019 and held it in 3 quarters.
Axa's Omnicell position peaked at $8.1M in Q2 2019.
298 funds tracked by Wall St. Rank held Omnicell as of Q4 2019.

Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.